Tobira Therapeutics (TBRA) Tops Q4 EPS by 2c

Tobira Therapeutics (NASDAQ: TBRA) reported Q4 EPS of ($0.50), $0.02 better than the analyst estimate of ($0.52).

For earnings history and earnings-related data on Tobira Therapeutics (TBRA) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c